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Abstract The abnormalities caused by excess fat accu-
mulation can result in pathological conditions which are
linked to several interrelated diseases, such as cardiovas-
cular disease and obesity. This set of conditions, known as
metabolic syndrome, is a global pandemic of enormous
medical, economic, and social concern affecting a signiﬁ-
cant portion of the world’s population. Although genetics,
physiology and environmental components play a major
role in the onset of disease caused by excessive fat accu-
mulation, little is known about how or to what extent each
of these factors contributes to it. The worm, Caenorhab-
ditis elegans offers an opportunity to study disease related
to metabolic disorder in a developmental system that pro-
vides anatomical and genomic simplicity relative to the
vertebrate animals and is an excellent eukaryotic genetic
model which enable us to answer the questions concerning
fat accumulation which remain unresolved. The stored
triglycerides (TG) provide the primary source of energy
during periods of food deﬁciency. In nature, lipid stored as
TGs are hydrolyzed into fatty acids which are broken down
through b-oxidation to yield acetyl-CoA. Our recent study
suggests that a member of C. elegans Kru ¨ppel-like factor,
klf-3 regulates lipid metabolism by promoting FA b-oxi-
dation and in parallel may contribute in normal reproduc-
tion and fecundity. Genetic and epigenetic factors that
inﬂuence this pathway may have considerable impact on
fat related diseases in human. Increasing number of studies
suggest the role of mammalian KLFs in adipogenesis. This
functional conservation should guide our further effort to
explore C. elegans as a legitimate model system for
studying the role of KLFs in many pathway components of
lipid metabolism.
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Introduction
Lipid catabolic pathways and metabolic disorder
Cells and organisms are profoundly inﬂuenced by energy
changes that they continually experience throughout their
lives. Energy balance involves many interactions between
various tissues and signaling pathways. Thus, the ability to
synchronize energy ﬂuctuation through various catabolic
and anabolic pathways in response to changing nutritional
status is critical for cellular and organismal behavior and
survival. Mammals have developed a mechanism to coor-
dinate various activities between tissues to store excessive
amounts of energy substrates in the form of intracellular
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Parton 2006). These lipid droplets are most prominent in
mammalian adipose tissues. Whereas the stored TGs pro-
vide the primary source of energy during periods of food
deﬁciency or when the energy demands exceeds nutrients
intake. Excessive nutrient uptake and deposition may cause
signiﬁcant health problems. Due to its homeostatic nature,
energy storage is coordinately regulated through many
signaling pathways that integrate fat deposition with its
mobilization and utilization throughout the body (Schwartz
et al. 2000). The consequences of poor lipid metabolism
can be severe and there is increasing evidence linking lipid
metabolism dysfunction to diabetes, heart disease, hyper-
tension, and polycystic ovarian syndrome.
Genetics, physiology, environmental components and
dietary habits can be major players in the onset of disease
caused by excessive fat accumulation; however, little is
known about how or to what extent each of these factors
contributes to it. The complexity of factors has made it
difﬁcult to recognize the speciﬁc roles for many of these
factors in the framework of human physiology. Despite
these difﬁculties there has been progress in understanding
of metabolic diseases given the complexity of vertebrate
systems. Highly complicated metabolic networks and
sensing mechanisms coordinate the ﬂow of fats through
synthesis, storage, and breakdown pathways (Lindsley and
Rutter 2004) and, therefore, a composite view of nutrient
uptake, transport, storage and utilization are required for its
understanding.
Cells break down carbohydrates, amino acids and fats to
generate ATP, the universal energy currency of cells.
Carbohydrates are broken down through glycolytic
enzymes to pyruvate and then further to acetyl-CoA to
generate NADH and FADH2 through the tricarboxylic acid
(TCA) cycle. NADH and FADH2 are used to generate ATP
via oxidative phosphorylation. Liberated fatty acids (FAs)
are then activated to their respective acyl-CoA derivates by
acyl-CoA synthases/ligases. Breakdown of fatty acyl-CoAs
to acetyl-CoA occurs via b-oxidation enzymes, where
several parallel pathways with intersecting substrate spec-
iﬁcities are used (Reddy and Hashimoto 2001). Identifying
the mechanism(s) by which fatty acid synthesis, transport
and breakdown pathways coordinate and thus interruptions
in these pathways may result in abnormal metabolic reg-
ulation is a major area of lipid biology research. It is not
surprising that the most challenging task is to categorize
the fundamental genetic component(s) controlling lipid
metabolism, and thus a simpler genetically tractable model,
such as Caenorhabditis elegans is needed (White 1988).
In mammals adipose tissue is the major storage site for
fat. Consequently, the amount of adipose tissue which can
be altered under the inﬂuence of various physiological
conditions in an animal may be a determinant of energy
homeostasis. Studies into preadipocyte and ﬁbroblast cul-
tured cell lines have led to abundance of data related to the
transcriptional cascades that govern adipogenesis. Sub-
sequent genetic studies involving transgenic and knock-out
mice have reached similar conclusions. Overall, many
published reports suggest that there are complex network
of transcription factors including activators, co-activators,
and repressors which coordinate the expression of hundreds
of proteins involving in many signaling pathways in the
progression of mature fat cells (Farmer 2006). In recent
years, members of the mammalian Kru ¨ppel-like factor,
KLF, family have been identiﬁed to be the key players in
the transcription network controlling preadipocyte forma-
tion, adipogenesis, lipogenesis, and obesity. Several
members KLF 2–7 and 15 are known to function in adi-
pogenesis (Oishi et al. 2005, 2008; Wu et al. 2005; Li et al.
2005; Birsoy et al. 2008; Sue et al. 2008). In an exciting
new discovery, type 2 diabetes and high-density lipoprotein
cholesterol-associated cis-acting expression quantitative
trait locus (eQTL) of the maternally expressed KLF14 is
shown to act as a master trans-regulator of adipose gene
expression (The MuTHER Consortium et al. 2011).
Because lipid metabolism is central to organismal energy
homeostasis, understanding how its deregulation is linked
to common disorders such as diabetes, obesity, and ath-
erosclerosis constitutes an important ﬁeld of biomedical
investigations.
The KLF family is a conserved, important class of
transcription factors, which are expressed in a variety of
cell types and control a wide range of cellular processes.
Members of KLF family are believed to function via their
interaction with different co-activators or repressors (Bie-
ker 2001; Kaczynski et al. 2003; van Vliet et al. 2006;
Turner and Crossley 1999). The KLF-mediated regulatory
networks that govern adipogenesis in mammals are com-
plex and still poorly understood; in particular, their
involvement in over all lipid biology has not been identi-
ﬁed in any organism. A number of research strategies have
been initiated in order to understand the detailed mecha-
nism used by various mammalian KLFs in the control of
adipogenesis. This would enable the identiﬁcation of
components function in concert with KLFs in biochemical
or cellular pathways involved in adipogenesis. The goal of
the research conducted in our laboratory is to study KLFs
in C. elegans genetic model system to identify the addi-
tional components of known and novel signaling pathways
that regulate lipid metabolism.
Many years of research into the genetics, biochemistry
and physiology of lipid metabolism in the murine model
system has contributed tremendously to the understanding
of mammalian energy homeostasis. Although the physiol-
ogy of the mouse is very different from human still there
are many conserved features that govern metabolism in
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other species including C. elegans. However, C. elegans is
far more different from human. Thus, a simple and rational
approach to the identiﬁcation of molecular pathways con-
trolling lipid metabolism in worm and human is to ignore
the physiological differences and focus only on the con-
served features that exists between the two. Many of the
regulatory genes involved in C. elegans lipid metabolism
have their orthologous genes in human, which are involved
in adipocyte biology. Caenorhabditis elegans as a genetic
tool can offer a powerful means to exploit the conserved
molecular pathways of fat metabolism and the associated
diseases that may arise as a result of alteration in these
pathways (Ashraﬁ 2005; Mullaney and Ashraﬁ 2009; Brey
et al. 2009; Watts 2009). The worm has remarkable ability
to sense nutrient availability and then coordinate its phys-
iological and metabolic responses to use it for energy
demand which may suggest a conserved mechanism(s) for
nutrient regulation and survival responses (Mair and Dillin
2008; Carrano et al. 2009). We use C. elegans as a tool to
study the genetics of lipid metabolism. This review focuses
on the essential role of KLF in lipid metabolic pathways.
Diseases associated with poor fat metabolism
Energy storage is a basic universal adaptive mechanism in
all animals from small organism, such as C. elegans to
humans, that allows organisms to face uncertainties
regarding food availability. As a complex, multi-factorial
trait driven by natural selection on food availability, fat
storage is a highly regulated and dynamically balanced
process. Both excesses (obese) and deﬁciencies (lipodys-
trophy) in energy homeostasis have devastating pathologic
consequences. In response to fasting or feeding, it is
important that organisms properly control the balance of
energy storage and expenditure. Abnormal lipid ﬂux and
excessive fat deposition has been recognized as a leading
risk factor that contributes to diabetes and obesity. In its
full-blown state, type-2 diabetes (T2D) manifests two
hallmarks in clinical patients, insulin resistance and b-cell
failure. It is generally agreed that obesity preconditions
insulin resistance in humans that in turn, produces T2D
(Reaven 2005; Kahn and Flier 2000). Excessive fat depo-
sition in insulin effector cells, such as hepatocytes, muscle
cells, and adipocytes, can decrease the sensitivity of these
cells to insulin and ultimately result in insulin resistance.
On the other hand, fat accumulation in nonadipose tissues
may bring about lipotoxicity; and this lipotoxicity to pan-
creatic islets can diminish and impair b-cell function by
disrupting insulin supply and affecting insulin biosynthesis,
processing, and secretion (Muoio and Newgard 2008).
Abnormal fat deposition may trigger inﬂammatory
responses, which in turn cause damage to both effector and
source cells of insulin. Adult onset T2D is a pressing health
issue with a disturbing epidemic forecast. It is a multifac-
torial disease involving changes in both conserved cores
(pathway/network of glucose/lipid metabolism) and adap-
tive conduits for nutrient intake, storage, and sensing. Yet
remarkably little is known about metabolic factors that are
responsible for causing insulin resistance and pancreatic b-
cell failure. Although disorder of glucose metabolism is the
primary culprit due to the malfunction of the insulin sys-
tem, the same signaling pathway also regulates lipid
metabolism in a coordinate fashion. It is generally believed
that perhaps metabolic pathways are not simply regulated
at the level of substrate ﬂux, but it is also possible that
these pathways are physically restructured as a result of
metabolic pressure. Examining how fat metabolism path-
ways are restructured may provide some clue into how
feeding behavior can inﬂuence basal metabolic rate.
Mammalian Kru ¨ppel-like factors: multiple roles
in lipogenesis and adipocyte differentiation
Excess food intake and absence of energy release appears to
disturb the normal metabolic process, resulting in over-
production of cholesterol and lipids. The carbohydrates
present in the diet can be stored as glycogen in the liver and
muscle, but can also be converted to TG in the liver and
transferred to adipose tissue, which is the main storage site
for TG. The deposition of TG is a very efﬁcient energy
reserve. There are two types of adipose tissue, the white
adipose tissue (WAT) and the brown adipose tissue (BAT).
White adipose tissue serves as an important endocrine organ
by producing hormones and a number of proteins. It is
vigorously engaged in many physiological processes,
including the regulation of energy. The WAT has a critical
role in long-term energy storage and has been associated
with, the two major metabolic processes, lipogenesis and
lipolysis. The primary function of the brown adipose tissue
is to generate heat to regulate energy balance.
There has been increasing interests in studying the
mechanisms underlying adipose tissue differentiation and
function. Current literatures identify a few notable tran-
scription factors that are apparently essential in the tran-
scriptional regulation of adipocyte differentiation and
development. Whereas members of peroxisome prolifera-
tor-activated receptors (PPARc), C/EBPa, (CCAAT/
enhancer-binding proteins) and the basic-helix-loop-helix
protein ADD1/SREBP (sterol regulatory element binding
proteins) families are essential factors in mammalian adi-
pogenesis (Rosen et al. 2000a; Rosen and Spiegelman
2000b), members of the mammalian KLF have been
identiﬁed recently as key transcription factor controlling
preadipocyte formation, adipogenesis, lipogenesis, and
obesity. Recent key studies on the biological role of KLF in
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of transcription factors within the lipid biology community.
It has been known that KLFs function via their interaction
with different co-activators or repressors (Turner and
Crossley 1999) and the characteristic feature of this family
is the presence of three zinc ﬁngers, which binds to
CACCC elements and GC-rich regions of DNA, to mediate
transcription. Currently, the human KLF family has 17
members, which are expressed in a variety of cell types and
related to SP1-like family members (Bieker 2001; Ka-
czynski et al. 2003; van Vliet et al. 2006). Because KLFs
bind to similar GC-rich sites or CACCC-boxes (Zhang
et al. 2005) and exhibit differential or overlapping tissue
distributions, there are potentially a large number of pos-
sibilities with regard to their regulatory mode and speci-
ﬁcities in executing convergent and divergent functions.
Perhaps this may be the reason why the exact function of
KLFs in vivo and their target speciﬁcity in vitro is not
clearly understood. Notably, some individual KLF mem-
bers perform speciﬁc functions in vivo, yet exhibit highly
similar DNA binding properties in vitro (Haldar et al.
2007). Certain members, i.e., KLF2, KLF3, KLF4, KLF5,
KLF6, KLF7, and KLF15 are key players of the network
controlling adipocyte differentiation and adipogenesis (Wu
et al. 2005; Li et al. 2005; Birsoy et al. 2008). For instance,
KLF2 is widely expressed in adipose tissue where it
functions as a negative regulator of adipogenesis. Over-
expression of KLF2 inhibits peroxisome proliferator-acti-
vated receptor-gamma (PPARc), but not the upstream
regulators C/EBPb and C/EBPd. By promoter analysis, a
binding site mediating this inhibitory effect was identiﬁed
within the PPARc2 promoter (Banerjee et al. 2003). In
3T3-L1 cells, forced expression of KLF3 blocks adipocyte
differentiation through a direct association with C/ebpa
promoter, whereas a decrease in KLF3 prevents differen-
tiation. In addition, KLF3 inhibits transcription by
recruiting to its N-terminal repression domain to the co-
repressor C-terminal binding protein (CtBP) (Turner and
Crossley 1998). In studying the transcriptional regulation
of adipogenesis, Birsoy et al. reported that KLF4 is a
regulator of early adipogenesis induced in 3T3-L1 cells
within 30 min after exposure to a standard cocktail of
insulin, glucocorticoids, and IBMX. Their data further
suggests that eliminating klf4 activity inhibits adipogenesis
while down-regulating C/EBPb (Birsoy et al. 2008).
Kru ¨ppel-like factor 6 (klf6) a tumor suppressor gene, pro-
motes adipogenesis by the transcriptional suppression of
proto-oncogene delta-like 1 (dlk1), a gene encoding a
transmembrane protein that inhibits adipocyte differentia-
tion through interaction with HDAC3 (Li et al. 2005).
HDAC3 deacetylase has been implicated in repressing
PPARc function by interacting with hypophosphorylated
retinoblastoma (pRb) (Fajas et al. 2002). Although pRb
interacts with a large number of growth-promoting tran-
scription factors (Ferreira et al. 2001; Wade 2001), studies
suggest that pRb phosphorylation may be involved in
preadipocyte differentiation (Classon et al. 2000). Li et al.
(2005) demonstrated that KLF6 could moderate adipocyte
differentiation independent of Rb through transcriptional
activation of adipocyte inducers like PPARc, C/EBPa/b,
and stearoyl-CoA desaturase-1 (SCD1). Kru ¨ppel-like factor
7 (KLF7) has also been implicated as a negative regulator
of adipogenesis. In the insulin secreting cell line (HIT-T15
cells), overexpressed KLF7 signiﬁcantly suppressed glu-
cose-induced secretion of insulin and reduced the expres-
sion of PPARc and C/EBPa, thereby, blocked adipogenesis
(Kawamura et al. 2005). KLF15 promotes adipogenesis by
its expression in adipocytes and myocytes in vivo and is
induced when 3T3-L1 preadipocytes differentiate into
adipocytes (Li et al. 2005; Mori et al. 2005), but it also up-
regulates GLUT4 in both adipose and muscle tissues (Gray
et al. 2002, 2007). There is evidence that KLF5 has an
essential role in fat cell differentiation, where KLF5 was
induced at an early stage of 3T3-L1 preadipocyte differ-
entiation, followed by PPARc2 induction (Oishi et al.
2005).
C. elegans: simple animal model to study lipid
metabolism
The dramatic rise in the prevalence of diseases caused by
metabolic disorders globally is a compelling reason to
search for a model to study lipid metabolism, which is
amenable to genetics. The C. elegans is a microscopic
worm occurs mainly as inbred self-fertilizing hermaphro-
dites; however, rare male contributes at a very low rate of
out-crossing. C. elegans offers a relevant model to eluci-
date the molecular genetics of lipid biology (Jones and
Ashraﬁ 2009) that matches the available mouse model, and
thus has the potential to ﬁll the gap between in vitro and in
vivo studies in mammals. The advantage of using C. ele-
gans models to study lipid metabolism is its genomic
databases and the availability of mutants associated with
lipid metabolism. The C. elegans mutant strains can be
generated efﬁciently with readily identiﬁable phenotypes
and less complex genotype. The worm has the ability to
synthesize saturated and unsaturated fatty acids de novo
(Rothstein 1970), and it typically stores energy as lipids
(triglycerides, phospholipids) which are directly absorbed
from the bacterial food. The C. elegans stores fat primarily
in cells of its intestine, a derivative tissue of the developing
layer of endoderm and composed of several types of gut
granules containing protein, carbohydrate, and lipid fat
granules. Signiﬁcantly, the intestine serves as the major site
for fat storage (Brock et al. 2006), and for FA metabolism,
which are regulated through insulin, TGF-b, and serotonin
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123signaling pathways (Greer et al. 2008; Kimura et al. 1997;
Sze et al. 2000; Ashraﬁ et al. 2003). In contrast, mamma-
lian fat is derived from mesodermal tissue, which contains
one cell type, the adipocyte. The mammalian adipocyte is
dedicated to homeostasis of fat metabolism, while the
worm intestine performs many functions. Although dis-
tinct, the common denominator is the genetic conservation
between the regulation of fat granules in C. elegans and
mammalian adipocytes (McKay et al. 2003). Many of the
disease-associated effects of excess fat accumulation in
humans are unlikely to occur in worm, yet the few studies
reported thus far uncover signiﬁcant similarities between
molecular components of mammalian and C. elegans fat
pathways that extend to disease-associated genes. C. ele-
gans has neither blood circulation nor pancreatic islets, but
its glucose/lipid metabolic pathways and various regulatory
systems are conserved (Ashraﬁ 2005). For instance, worms
with defective daf-2 genes corresponding to insulin resis-
tance and diabetes build up fat deposits instead of metab-
olizing glucose (Kimura et al. 1997). Although worm uses
insulin to control both its fat metabolism and its hiberna-
tion program, the worm does not live long enough to
develop diabetes, but seems to have the same genetic
pathways associated with human diabetes. The emerging
model of lipid storage and endocrine regulation are similar
in humans and C. elegans, suggesting it will be a good
genetic model for the study of lipid storage diseases in
humans. The availability of worm mutants with human
counterparts (*50% of human disease genes have worm
homologs; Hodgkin et al. 1998) along with demonstrated
translation of C. elegans results to mammalian systems,
provides a valuable entry point for in-depth analyses in
both worm and mammals (Ashraﬁ 2005; Mullaney and
Ashraﬁ 2009; Brey et al. 2009; Watts 2009). The worm
may also provide therapeutic targets for emerging prob-
lems associated with obesity and other metabolic disorders.
Conserved pathways in worms and humans:
fat-regulating genes in C. elegans
The regulation of fat storage in C. elegans involves a com-
plex network of proteins with likely functions in neuroen-
docrinesignaling(Jeongetal.2005;Renetal.1996),uptake,
transport (Ashraﬁ et al. 2003), and storage (McKay et al.
2003).Thegreatresourceofgeneticandbehavioraltoolsthat
is available makes C. elegans an excellent system for
unraveling complex fat metabolic pathways. Ashraﬁ et al.
(2003) used genome-wide RNAi analysis and identiﬁed a
plethora of genes affecting lipid metabolism, which under-
scores the conserved nature of molecular mechanisms in fat
storagebetweenwormandmammals.Theyobservedthatthe
products of these genes belong to metabolic enzymes, tran-
scription factors, signal transduction modules, and nutrient
transporters, reﬂecting a wide range of biochemical identi-
ties and pathway activities. Selective inactivation of those
worm genes homologous to known mammalian lipid
metabolism regulatory factors have also demonstrated the
existence of molecular players serving as master switches at
the level of gene transcription and signal transduction.
Examples include transcription factors SREBP and C/EBP,
which cause a lipid-depleted phenotype when mutated
(McKay et al. 2003), and the regulation of stearoyl-CoA
desaturases (SCD) by nuclear hormone receptor (NHR-80)
to keep an optimal FA composition (Brock et al. 2006). The
mutationinnhr-49generesultsinaphysiologicallydifferent
outputs; increased fat accumulation and decreased life span
in worms (Van Gilst et al. 2005). But nhr-49 is also a key
regulator of the pathways controlling fat consumption and
maintaininganormalbalanceofFAs.Althoughthesestudies
have focused on C. elegans genes they raise the intriguing
possibility of parallel conserved mechanisms in mammals.
The C. elegans zinc ﬁnger factors
The C. elegans genome encodes three members: klf-1, klf-2
and klf-3 that contain three highly conserved C2H2 zinc
ﬁngers. These KLFs share the highest identity with mem-
bers of mammalian KLFs in their C-terminal C2H2 zinc
ﬁngers, but have little homology in their N-terminal
regions. We investigated the function of C. elegans klf-1
and C. elegans klf-3 and demonstrated that both worm klfs
are critical regulators of lipid metabolism (Hashmi et al.
2008; Zhang et al. 2009). The C. elegans klf-1 expresses in
intestine (Fig. 1), and in addition to its function in lipid
metabolism this gene is also involved in germline cell
death and phagocytosis (Hashmi et al. 2008). An increase
in fat accumulation in the absence of Ce-klf-1, its
Fig. 1 Images of klf-1::gfp expression in the transgenic worm. As
shown, klf-1::gfp expression seen as green ﬂuorescent in intestinal
segments covering the most part of young adult worm C. elegans.
Transgenic worms were observed and paragraphed using Axioskop 2
plus ﬂuorescent microscope with appropriate ﬁlter sets (9400
magniﬁcations)
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ment, as well as the continued presence in adult worms is
consistent with its role in lipid metabolism; a disturbance in
this process may increase cell death and cause the defective
phagocytosis of dead cells. However, several questions
remained unanswered. For example, it is unclear that how
does klf-1 function in germline cell death and/or phago-
cytosis while it does not seem to express in germline? and
what are the critical regions within klf-1 cis-regulatory
elements that control its expression? We are investigating
the underlying molecular mechanisms which lead to the
increased fat accumulation, cell death, and phagocytosis
following klf-1 misregulation.
Lipid metabolism is a complex process requiring a
number of molecules involved in the absorption, biosyn-
thesis, assembly, transport and catabolism of diverse lipids.
The suppression of klf-1 activity may result in a failure in
to regulate the speciﬁc genes needed in one or more of
these processes. The complex and extensive array of met-
abolic abnormalities that result from excess fat accumula-
tion may also be linked to excessive cell death.
Alternatively, cell death may have occurred as result of a
failure to induce the genes required to prevent cell death.
To elucidate whether klf-1 functions in a known regulatory
pathway or in a yet unknown new pathway, a thorough
analysis of the cellular functions of C. elegans klfs,
accompanied by a scrutiny of their interactions with each
other and other molecular components of fat regulatory
pathways is needed.
Another member of KLF family, klf-3 may be one of the
important regulators of two key processes in lipid metab-
olism; FA b-oxidation and lipoprotein assembly and
transport. Mutation in Ce-klf-3 (ok1975) gene not only
results in the accumulation of large amount of fat droplets
in mutant intestine (Zhang et al. 2009), but also mutant
worm fails to reproduce normally. As reproduction is an
energy requiring process, which is modulated by the
availability of nutrients including lipids suggests a link
between fat accumulation and reproduction. In fact, several
studies have suggested endocrine roles of mammalian
adipose tissue and the reproductive system in regulation of
life span (Blu ¨her et al. 2003; Hwangbo et al. 2004; Gian-
nakou et al. 2004). We are attempting to understand whe-
ther reproductive failure in klf-3 (ok1975) mutant is
associated with its fat accumulation. Fat storage has a
central role in the natural selection and evolution of met-
azoans. It offsets food shortage, a constant threat to animal
survival (except humans of recent evolution) (Sto ¨ger
2008), and is most likely to have arisen ﬁrst in the intestine,
known to be the most ancient organ (Ashraﬁ et al. 2003).
The intestine speciﬁcity of a C. elegans klf-3 gene (Fig. 2a)
and its identiﬁcation as a key factor in fat regulation
reinforces the early origin and adaptation of this genetic
mechanism in lipid metabolism and energy homeostasis.
This concept is also corroborated by the presence and
function of its cousin klf-1 in the intestine. Although many
more studies are needed, the results thus far support the
notion that C. elegans klf-3 has a signiﬁcant role in
Fig. 2 Images of klf-3::gfp expression in the transgenic worm. As
shown, klf-3b::gfp expression (green ﬂuorescent) is seen in intestinal
segments covering the whole intestinal region of a (a) C. elegans
adult worm, but absent from gonadal region (arrows showing gray
area adjacent to green ﬂuorescent), and all other organs and tissues, in
this image expression of GFP is merged with DIC images for clarity.
Transgenic worms were observed and paragraphed using Axioskop 2
plus ﬂuorescent microscope with appropriate ﬁlter sets (9400
magniﬁcations). Oil-Red-O staining of (b) wild-type C. elegans that
has very low fat mass; (c) increased fat mass can be seen in klf-3
(ok1975) mutant animal. The intensity of red staining (arrows) was
clearly several folds higher in klf-3 (ok1975) mutant than wild-type
animal. Animals were observed under Nomarski optics attached to a
light microscope Nikon eclipse 80i and photographs were taken with
a digital camera Photometric cool snap Cf (9400 magniﬁcations)
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pathways, which collectively manifest regulatory mecha-
nism for fat storage. The results have signiﬁcant implica-
tions in respect to the human counterparts of the gene in
terms of disease–gene association. Identiﬁcation of C.
elegans klfs as regulator of fat metabolism holds the
promise to examine the speciﬁc metabolic pathways that
contribute to mammalian lipid homeostasis.
Secondary defects of fat accumulation
As the expression of C. elegans klf-3 is predominantly in
the intestine, suggesting that klf-3 may affects reproduction
through its role in the intestine, the site of fat metabolism
and yolk synthesis. Yolk is transported to the gonad to
provide nutrients for growing oocytes. The intestine in
worms could also act as the endocrine organ and regulate
energy balance and also function as a sensor for nutrient
availability. Thus sensing the amount of stored fat, the
intestine would signal either germ cell arrest or growth of
the germline, hence connecting reproduction, and fat stor-
age. It is, therefore, pertinent to address the relationship
between excess fat accumulation and reproduction.
KLF-3 mediated regulation of C. elegans fatty acid
synthesis pathway
In C. elegans, the fat phenotype of klf-3 (ok1975) mutant
(Fig. 2b) suggests that the deletion of this gene may have
caused disruption in signal transduction associated with
lipid metabolism. We tested this hypothesis by performing
microarray and qRT-PCR. We found that the expression of
genes devoted to the regulation of FA desaturation and b-
oxidation pathways (Table 1) (Van Gilst et al. 2005) were
altered in the mutant worm (Zhang et al. 2009). We
observed elevated transcript levels in fat-1, fat-3, fat-4, fat-
5, and fat 6, but at the same time a signiﬁcant decrease in the
mRNA transcripts of fat-7 suggesting klf-3 could differen-
tially regulate these fat genes in the maintenance of proper
enzymatic activities via balancing actions. Klf-3 maintains
the balance of saturated and monounsaturated FAs by reg-
ulating the expression of fat-1, fat-3, fat-4, fat-5, fat 6 and
fat-7 genes, which in turn catalyze the biosynthesis of
monounsaturated C16:1 and C18:1 FAs from saturated
C16:0 and C18:0 FAs (Watts and Browse 2000). Although
additional factors appear to be necessary it is likely that the
fat phenotype of the klf-3 (ok1975) mutants is a result from
aberrant ratio of saturated to monounsaturated FAs. In
support of above hypothesis, lipid analysis data indicate an
alteration in the relative abundance of C16:0, C18:0, and
C18:2w6c in klf-3 mutants (Zhang et al. 2009). Deletion in
the klf-3 gene also results in a several fold increase in fat-3
expression. As fat-3 is required for C20 synthesis a change
in the amount of C20 fatty acids is anticipated. In fact, in a
previous study we observed a reduction in C20:2w6c fatty
acids in the klf-3 (ok1975) mutant worms (Zhang et al.
2009). Consequently, we suggest a plausible model
whereby KLF-3 protein selectively acts on key FA syn-
thesis signaling modules to mediate their activities and
integrate their crosstalk into a fat regulation network.
Mono-unsaturated fatty acids (MUFAs) are essential
components of both membrane phospholipids and TG,
playing criticalrolesinvital cellularprocesses(Agathaetal.
2001), most importantly in energy storage. MUFAs are
synthesized from saturated FAs by SCDs also called D9
desaturases (Cohen and Friedman 2004). An appropriate
ratio between MUFAs and saturated FAs is important for
energy balance (Ntambi 1995) and disruption in the
‘‘appropriate’’ ratio been linked to pathological conditions
including cardiovascular disease, diabetes, obesity and
cancer (Ntambi et al. 2004; Simopoulos 1999; Bhathena
2000;Cohenetal.2003).WattsandBrowse(2000)observed
that C. elegans can synthesize a wide variety of FAs using
D12, D3, D5, D6, three D9 desaturases (Watts, and Browse
2000), and elongases (Watts and Browse 2002). Thus far,
Brock et al. 2006, 2007 have identiﬁed three D9 desaturases
encoded by the genes fat-5, fat-6, and fat-7 in C. elegans.
SinceinbothvertebratesandininvertebratesD9desaturases
has key function in cellular lipid partitioning and homeo-
stasisitmaybeapotentialtargetfortherapeuticintervention
to control obesity and other aspects of metabolic syndrome
(Dobrzyn and Ntambi 2005). This may be supported by the
Table 1 List of genes predicted to participate in fatty acid compo-
sition, and b-oxidation
C. elegans genes Mammalian name
FA composition
Fat-1 Omega 3 desaturase
Fat-2 D12 desaturase
Fat-3 D6 desaturase
Fat-4 D5 desaturase
Fat-5 D9 desaturase
Fat-6 D9 desaturase
Fat-7 D9 desaturase
b-oxidation
Acs-1 Acyl-CoA synthase (ACS)
Acs-2 Acyl-CoA synthase (ACS)
F08A8.1 Acyl-CoA oxidase
F08A8.2 Acyl-Co oxidase
F44C4.5 Palmitoyl protein thioesterase
T05G5.6 Trifunctional enzyme (ECH)
Cpt-1 Carnitine palmitoyl transferase
Cpt-3 Carnitine palmitoyl transferase
Cpt-6 Carnitine palmitoyl transferase
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causes excess lipid accumulation and is linked to obesity,
insulin resistance and diabetes (Hulver et al. 2005).
KLF-3 regulation of fatty acid b-oxidation
It is clear that FA b-oxidation is the major energy-produc-
ing metabolic pathway in eukaryotes. When the serum
glucose levels are low, a signal is sent to the pancreas to
secrete an enzyme called glucagon. The purpose of this
enzyme is to stimulate adipose lipase activity to release FAs
from TG. These liberatedor free FAs pass through the blood
to other tissues, such as muscle where they are oxidized via
the b-oxidation pathway (Eaton et al. 1996). Most b-oxi-
dation takes place in the mitochondrial matrix. Fatty acids
are activated in the ﬂuid component of cell cytoplasm by
esteriﬁcation with Coenzyme A (CoA) to form acyl-CoA.
While activated medium-chain FAs (C8 and C10) can easily
diffuse into mitochondria, the long-chain FAs ([C18) need
to be actively transported from the cytoplasm into mito-
chondria by an enzyme carnitine palmitoyl transferase
(CPT) (Eaton et al. 1996). Substantial biochemical evidence
suggests that b-oxidation pathway begin with the addition
of coenzyme A to a FA and by four successive enzymatic
steps or cycles. Each of the FA is shortened by a two-carbon
fragment removed as acetyl coenzyme A, which then goes
through another round of b-oxidation, continuing to oxidize
and shorten even-chain FAs until they are fully converted to
acetyl-CoA (Reddy and Hashimoto 2001). Acetyl-CoA is
the vital substrate for synthesis of FAs. The b-oxidation of
long-chain FAs is a key source of energy production and,
therefore, many genes that encode the molecular compo-
nents of this system may underlie lipid disorders. Genetic
disorders of mitochondrial FA b-oxidation have been rec-
ognized as an important cause of morbidity and mortality,
highlighting the essential roles of this pathway in lipid
homeostasis and energy metabolism.
We found that many metabolic gene products are
potential targets of klf-3. Some essential genes involved in
b-oxidation decreased mRNA level in klf-3 (ok1975)
mutant, which may lower the capacity to breakdown long-
chain FAs. We further found that klf-3 maintains the bal-
ance of saturated and monounsaturated FAs by regulating
the expression of FA D9-desaturase genes (Zhang et al.
2009), which in turn catalyze the biosynthesis of mono-
unsaturated from saturated FAs (Watts and Browse 2000).
The C. elegans physiology is similar to human in that some
homologs of mammalian b-oxidation enzymes contain
mitochondrial signal peptides whereas others contain per-
oximal signal peptides indicating that both cellular com-
partments can carry out the oxidation of fatty acids.
Non-esteriﬁed free fatty acid (NEFA) is used for energy
generation in b-oxidation. Essentially all cells take up
excess NEFA and convert it to energy-rich neutral lipids in
the form of TG, which is packaged into lipid droplets.
NEFA is regenerated from lipid droplet stores to meet
metabolic and energy needs, and lipid droplets protect cells
against lipotoxicity by sequestering excess NEFA. Perox-
imal b-oxidation dysfunction has been implicated in lipid
droplets expansion in C. elegans (Zhang et al. 2010). Thus
our ﬁnding that the intestine cells in the klf-3 (ok1975)
mutant formed large lipid droplets, may have been the
result of defective b-oxidation. Genotypic and phenotypic
analysis of klf-3 (ok1975) mutant (Zhang et al. 2011) has
uncovered a strong genetic interaction of klf-3 with several
genes encoding fat metabolic enzymes, i.e., acyl-CoA
synthetase (acs-1 and acs-2), acyl-CoA oxidase (F08A8.1
and F08A8.2), and stearoyl-CoA desaturase (SCD, fat-7).
Acyl-CoA synthetase, and acyl-CoA oxidase are key FA b-
oxidation enzymes (Osumi et al. 1980).
Zhang et al. (2011) studied F08A8.1 (ok2257) mutant
animals and found that they show normal growth and
development proﬁles, but displayed *45% increase in the
fat accumulation in the intestine as compared to the wild-
type. Therefore, the fat accumulation and reproductive
defects are the shared phenotypes common to the klf-3
(ok1975) and F08A8.1 (ok2257) mutants. Zhang et al.
(2011) further observed epistasis between klf-3 (ok1975)
and F08A8.1 (ok2257) mutants. They constructed strains
that were homozygous for the klf-3 (ok1975) deletion and
homozygous for F08A8.1 (ok2257) deletion and assayed
for fat deposition phenotype in the progenies of klf-3
(ok1975); F08A8.1 (ok2257) double mutant by Oil-Red-O
staining. They observed that the double mutant accumu-
lated approximately 40% more fat than either klf-3
(ok1975)o rF08A8.1 (ok2257) single mutants and 85%
more fat accumulation than the wild-type animals. These
phenotypes of the double mutant suggest that the klf-3 and
F08A8.1 genes quite likely function in the same genetic
pathway and the deletion of F08A8.1 in klf-3 (ok1975)
mutant background enhances fat accumulation in the dou-
ble mutant. In a similar experiment, Zhang et al. (2011)
applied F08A8.2 RNAi on wild-type animals and found a
20% increase in fat accumulation in F08A8.2 RNAi ani-
mals over wild-type. However, RNAi depletion of F08A8.2
in klf-3 (ok1975) mutant background neither increased nor
decreased the level of fat mass in F08A8.2 RNAi; klf-3
(ok1975) mutant; the fat mass remained the same as klf-3
(ok1975) single mutant. Whereas suppressing or eliminat-
ing the activity of both F08A8.1 and F08A8.2 in klf-3
(ok1975) mutant displayed a similar level of fat accumu-
lation to that of F08A8.1; klf-3 (ok1975) double mutant.
In further experiments Zhang and colleagues (2011)
examined the effect of acs-1 RNAi on the fat content in
wild-type genetic background. They found that acs-1 RNAi
exhibited stronger staining (40%) with Oil-Red-O than the
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acs-1 RNAi both produce an increased fat uptake pheno-
type, Zhang and colleagues (2011) performed acs-1 RNAi
on both wild-type and klf-3 (ok1975) mutant worms and
examined their fat uptake phenotype. They found that
RNAi depletion of acs-1 had no effect on fat accumulation
in klf-3 (ok1975) mutant animals; all acs-1 RNAi treated
strains had similar fat mass *40% increase over wild-type
animals indicating that acs-1 activity is not necessary for
the fat storage induced by the absence of klf-3.
The analysis of the klf-3 (ok1975); acs-2 (ok2457)
double mutant also revealed a key role of KLF-3 in mito-
chondrial b-oxidation pathway regulation in C. elegans
(Zhang et al. 2011). As in mammals the acs-2 gene encodes
acyl-CoA synthetase-2 (ACS-2), which activates fatty
acids and converts them to acyl-CoA for lipid metabolism.
Worm acs-2 apparently expresses in mitochondria and is
positively regulated by the nhr-49 nuclear receptor (Van
Gilst et al. 2005). Over-expression of acs-2 gene has been
reported to suppress the high-fat phenotype of nhr-49
mutant and fat-7 inhibits acs-2 expression to prohibit fat
consumption (Van Gilst et al. 2005). Compared with these
data, Zhang et al. (2011) observed a reversed situation, i.e.,
a marked increase of acs-2 and a concurrent decrease of
acs-1, F08A8.1 and fat-7 in klf-3 (ok1975) mutants. Hence,
the high expression of acs-2 and the low expression of fat-7
in mutants may arise from coordinated tuning of fat
metabolism. Although the phenotype of increased fat
accumulation in klf-3 (ok1975) mutant, acs-1RNAi animals
and acs-2 (ok2457) mutant animals are similar, the fat
phenotype caused by klf-3 mutation is not changed by
eliminating activity of either acs-1 or acs-2. The relation-
ship between klf-3 and acs-2 may be partly inﬂuenced by
fat-7 whose decreased expression is expected to promote
acs-2 gene activation (Van Gilst et al. 2005).
Fatty acid breakdown via b-oxidation occurs in peroxi-
somes and this multi-step process is balanced with its mobi-
lization and TG assimilation in terms of energy storage and
redistribution(ReddyandMannaerts1994).Collectively,our
biochemical,morphologicalandgeneticanalyseshaveledus
to thefollowing conclusion: klf-3 is a critical regulatorof FA
metabolism in C. elegans and it integrates the expression of
FAb-oxidationpathwaycomponentsandthattranscriptional
regulation of F08A8.1, acs-1 and acs-2 genes by klf-3 con-
tributestoFAb-oxidation.Althoughthismodelisappealing,
a puzzling question remains as to whether b-oxidation dys-
function also affects reproduction.
Consequences of poor fatty acid b-oxidation:
reduced reproduction
In addition to high-fat phenotype, the klf-3 (ok1975) mutant
animals are sterile (no progeny) and semi-sterile (reduce #
of progeny). Further analysis of the sterile mutant revealed
morphologically abnormal oocytes and disorganized
gonads. In fourth larval stage (L4) and early adult semi-
sterile worms, germ cells and oocytes appeared normal,
with no apparent difference in normal egg-laying. How-
ever, their oogenesis became impaired after 40–50 oocyte–
sperm fusion events. The degeneration of embryos began
with the appearance of disorganized clumps of dead cells in
the uterus. The gradual appearance of egg-laying defects in
the semi-sterile mutant worms could be due to the gradual
deterioration of certain klf-3 related activities (Zhang et al.
2009). In normal condition, the germ cells proliferate and
develop during early larval development in C. elegans.I ti s
tempting to speculate that during larval development the
worm makes an assessment of nutritional sufﬁciency which
inﬂuences germline proliferation. The germ cells pass
through three stages of development and differentiate into
developing oocytes. Once matured the oocytes are fertil-
ized and produce embryos (Schedl 1997). The development
of late stage oocytes and embryos depends on nutrients in
particular the yolk proteins.
In mammals, excess fat accumulation can bring about a
variety of changes in the reproductive system. Investiga-
tions into many obese animals have indicated a complete
infertility in the females and marked impairment of
reproductive function in the males (Bray 1997). The utili-
zation of lipid by developing oocytes and embryos to
generate energy through b-oxidation is an important area of
research which requires due attention. The evidence col-
lected thus far suggests that klf-3 is an essential regulator of
FA b-oxidation and its mutation affects FA breakdown and
normal fertility. It is tentative to speculate that fat accu-
mulation in the intestine may deprive reproductive organs
essential nutrients and that reproductive defects in the
mutant animals could be secondary to the buildup of fat.
Does klf-3 regulate lipid absorption/transport?
Dietary lipids are absorbed from the small intestines and
transported to various organs and tissues as well as to
maintain lipid/cholesterol homeostasis. Because of non-
polar nature of lipids, mammals have evolved a mechanism
that allows the conversion of insoluble lipids into lipo-
proteins so that it can be transported and delivered to its
destination. For transportation the assembly and secretion
of lipoprotein particles is important, which is primarily
achieved in the liver as very low density lipoprotein
(VLDL) and in the intestine as chylomicrons. The assem-
bly of triglyceride-rich lipoproteins requires the formation
of a complex between apolipoprotein B (apoB), a structural
protein, and microsomal triglyceride transfer protein
(MTP), an endoplasmic resident chaperone and protein
disulﬁde isomerase (PDI) (Bakillah et al. 1997; Rava et al.
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TG by nascent apoB for assembly and secretion of VLDLs
(Gordon and Jamil 2000; Davis 1999; Kang and Davis
2000; Sundaram et al. 2010). It is believed that MTP
transports lipid by a shuttle mechanism (Atzel and Wette-
rau 1993), suggesting that MTP acts as carrier to transfer
lipids from their site of synthesis to nascent lipoproteins
within the ER and thus able to transfer TG and other lipids
between membranes (Jamil et al. 1995). There is an array
of molecules that are involved in the translation and
translocation of secretory protein across the ER membrane
responsible for initial apoB folding to achieve lipid-binding
capability within the microsomal lumen. Thus, the regu-
latory mechanisms underlying assembly and secretion of
lipoproteins are important for understanding the patho-
physiology of various metabolic disorders.
MTP and apoB interact during lipoprotein assembly
(Wu et al. 1996; Patel and Grundy 1996) to facilitate
lipoprotein production and, therefore, eliminating or
reducing this interaction can reduce the level of apoB-
containing lipoprotein secretion. In mammals, there are
two extensively studied apoBs; apoB-100 is restricted to
the liver, whereas apoB-48 is localized in the intestine
(Kane et al. 1980; Krishnaiah et al. 1980; Sparks and
Marsh 1981). Studies of apoB components in knockout
mice have indicated that the assembly/secretion pathway of
apoB-containing lipoproteins has a critical role in the
transport of fat-soluble nutrients to the yolk sac (Higgins
and Hutson 1984). The lipid transfer activity of MTP is
essential for the assembly and secretion of apoB-containing
lipoproteins; inhibition of MTP decreases lipoprotein
secretion and lead to increased accumulation of lipids in
the liver (Hussain et al. 2003, 2008). Similar to mammalian
MTP, its C. elegans counterpart, dsc-4 has also been shown
to support secretion of apoB48 in Cos-7 cells (Rava et al.
2006; Rava and Hussain 2007).
The C. elegans dsc-4 encodes 892-residue protein that
is an orthologous to mammalian MTP (Shibata et al.
2003). The dsc-4 (qm182) mutant was isolated as a sup-
pressor of slow defecation phenotype of clk-1 (e2519)
mutant (Branicky et al. 2001) and thus named dsc-4
(defecation suppressor). Shibata et al. (2003) suggest that
lipoprotein assembly in intestine might be critical in
germline development in clk-1 mutants that are defective
in ubiquinone synthesis. The clk-1 gene encodes a highly
conserved demethoxyubiquinone (DMQ) hydroxylase that
is necessary for the biosynthesis of ubiquinone (Ewbank
et al. 1997) and its mutants require dietary ubiquinone for
their survival (Jonassen et al. 2001). In addition, Shibata
et al. (2003) found that germline development is desyn-
chronized in the clk-1 (e2519) mutant. For instance, in
contrast to wild-type hermaphrodites where sperms are
observed at fourth larval stage and oogenesis begins
shortly after the adult molt, the clk-1 (e2519) mutant
hermaphrodites have delayed germline development
which also results in delayed egg-laying (Shibata et al.
2003). Interestingly dsc-4 (qm182) mutant suppresses the
delayed germline and egg-laying phenotype of clk-1
mutant suggesting that dsc-4 acts by suppressing the slow
development of the germline.
Our qRT-PCR analysis of RNA isolated from klf-3
(ok1975) mutant animals displayed a signiﬁcantly reduced
expression of dsc-4 gene (Hashmi et al. unpublished). This
result suggests that klf-3 may have a role in the regulation
of dsc-4 gene. We further analyzed dsc-4 (qm182) mutant
animals for its fat contents. We found that the mutant
animals exhibited stronger staining with Oil-Red-O than
the control wild-type animals (Hashmi et al. unpublished).
The dsc-4 (RNAi) displayed similar fat staining as dsc-4
(mq920) mutant. Given that the klf-3 (ok1975) and dsc-4
(mq920) mutants, both produce an enhanced fat phenotype,
we examined whether mutation in dsc-4 (mq920) can
enhance or suppress the fat phenotype of the klf-3 (ok1975)
mutant. To investigate this possibility, we constructed dsc-
4 (qm182); klf-3 (ok1975) double mutant by standard
genetic crosses and stained them with Oil-Red-O dye. We
found that klf-3; dsc-4 mutant animals show an identical
increase in fat mass when compared with either klf-3 or
dsc-4 single mutant, showing a lack of synergism in the fat
accumulation phenotype of the double mutant.
We further investigated ﬁve C. elegans vit genes (vit-2-
vit-6) identiﬁed in the worm genome. These vit genes are
orthologous to mammalian apoB (Spieth et al. 1991;
Mann et al. 1999). The vit genes that encode yolk proteins
are also part of lipoprotein particles resembling the apoB
dependent LDL particles of vertebrates (Shibata et al.
2003). The C. elegans yolk is secreted from its site of
synthesis, the intestine, and is ultimately taken up into
vesicles (yolk granules) within the growing oocytes
(Kimble and Sharrock 1983) by a receptor-mediated
endocytosis pathway (Grant and Hirsh 1999). The primary
translation products are vitellogenins, which are cleaved
and modiﬁed to yield the mature yolk proteins (Sharrock
et al. 1990). Our microarray and RT-PCR analysis of klf-3
(ok1975) mutant displayed a signiﬁcantly reduced
expression of all vit genes in the mutant worm (Hashmi
et al. unpublished). These results suggest that abnormality
in the oocyte development and the resulting reproductive
failure in the klf-3 (ok1975) sterile or semi-sterile mutant
animals may have been caused by defects in the pro-
cessing and transport of yolk protein from intestine to the
gonads, where it is used as nutrient by the growing
oocytes. However, this assumption is yet to be veriﬁed
experimentally. Further biochemical and genetic analysis
of klf-3, dsc-4 and vit genes are in progress in our
laboratory.
68 3 Biotech (2011) 1:59–72
123Concluding remarks and perspectives
Fatty acids breakdown via b-oxidation occurs in peroxi-
somes and mitochondria wherein FA mobilization and TG
assimilation are balanced by a multi-step process in con-
texts of energy storage and redistribution. Possibly, klf-3
exerts its role in intestine via transcriptional regulation of
b-oxidation enzymes and thus affects their availability to
mitochondria or peroxisomes during FA breakdown for the
utilization of stored energy. We suggest that klf-3 can
function as either an activator or a repressor in the regu-
lation of some critical b-oxidation enzymes through their
genetic interactions. Because deﬁciency in enzymes of FA
b-oxidation underlies metabolic lipid disorders, our ﬁnd-
ings highlight the signiﬁcance of KLFs as key nodes of
network formation. In addition to its role in FA b-oxida-
tion, klf-3 is also involved in lipid transport. Given the fact
that klf-3 mutant animal builds up excessive amount of
triglycerides in its intestine, we suggest that they are unable
to efﬁciently mobilize stored lipids for energy. The lipid
absorption and transport to various tissues is a multifaceted
process which involves multiple steps including accumu-
lation of lipid, and transport through the secretory pathway.
In mammals, the assembly and secretion of lipoprotein
particles is important and that requires the formation of a
complex between apoB, and MTP. C. elegans DSC-4 and
VIT proteins are closely related to mammalian MTP and
apoB, respectively. Could these worm proteins have simi-
lar function as their mammalian counterpart and regulated
by klf-3? Because C. elegans dsc-4, klf-3 and vit genes all
express in intestine and their mutations produce a fat
phenotype, we can speculate that these C. elegans genes act
in concert to perform their speciﬁc function in the intestine.
Future in-depth experimental analyses should concentrate
on the identiﬁcation of the signals that communicate
nutritional status to the reproductive system and its asso-
ciated germline development. Genetic and epigenetic fac-
tors that inﬂuence this pathway may have considerable
impact on fat related diseases. The past several years have
witnessed a great advancement in our knowledge of the
regulatory role of KLF in adipogenesis. Yet, there is still a
large void in our understanding concerning the cascade of
events that result in KLFs activation, repression, and
interaction with other molecules in exerting their speciﬁc
functions in lipid metabolism. A reduction or failure in
catabolism or increased production of lipoproteins causes
hyperlipidemias which are risk factor for cardiovascular
diseases, diabetes and obesity. Our work in C. elegans klf
may bear broad implications for human lipid metabolic
disorders and offer a useful model system enabling us to
gain insights into the conserved regulatory mechanisms
that are otherwise difﬁcult to study in humans. Although
this review outlines the important of klf3 in fat metabolism,
it will be of critical importance to study its role in obesity
under physiologic/pathophysiologic states.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution and reproduction in any medium, provided the original
author(s) and source are credited.
References
Agatha G, Hafer R, Zintl F (2001) Fatty acid composition of
lymphocyte membrane phospholipids in children with acute
leukemia. Cancer Lett 173:139–144
Ashraﬁ K (2005) Obesity and the regulation of fat metabolism. The C.
elegans research community, WormBook ed, WormBook. doi:
10.1895/wormbook.1.7.1, http://www.wormbook.org
Ashraﬁ K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J,
Ruvkun G (2003) Nature. 421:268–272
Atzel A, Wetterau JR (1993) Mechanism of microsomal triglyceride
transfer protein catalyzed lipid transport. Biochemistry
32:10444–10450
Bakillah A, Zhou Z, Luchoomun J, Hussain MM (1997) Measurement
of apolipoprotein B in various cell lines: correlation between
intracellular levels and rates of secretion. Lipids 32:1113–1118
BanerjeeSS,FeinbergMW,WatanabeM,GrayS,HaspelRL,Denkinger
DJ, Kawahara R, Hauner H, Jain MK (2003) The Kru ¨ppel-like
factor KLF 2 inhibits peroxisome proliferator-activated receptor-c
expression and adipogenesis. J Biol Chem 278:2581–2584
Bhathena SJ (2000) Relationship between fatty acids and the
endocrine system. Biofactors 13:35–39
Bieker JJ (2001) Kru ¨ppel-like factors: three ﬁngers in many pies.
J Biol Chem 276:34355–34358
Birsoy K, Chen Z, Friedman J (2008) Transcriptional regulation of
adipogenesis by KLF4. Cell Metab 7:339–347
Blu ¨her M, Kahn BB, Kahn CR (2003) Extended longevity in mice
lacking the insulin receptor in adipose tissue. Science
299:572–574
Branicky R, Shibata Y, Feng J, Hekimi S (2001) Phenotypic and
suppressor analysis of defecation in clk-1 mutants reveals that
reaction to changes in temperature is an active process in
Caenorhabditis elegans. Genetics 159:997–1006
Bray GA (1997) Obesity and reproduction. Hum Reprod 1:26–32
Brey C, Nelder M, Gaugler R, Hashmi S (2009) Kru ¨ppel-like family
of transcription factors: an emerging new frontier in lipid
biology. Int J Biol Sci 5:622–636
Brock TJ, Browse J, Watts JL (2006) Genetic regulation of
unsaturated fatty acid composition in C elegans. PLoS Genet
2:997–1005
Brock TJ, Browse J, Watts JL (2007) Fatty acid desaturation and the
regulation of adiposity in Caenorhabditis elegans. Genetics
176:865–875
Carrano AC, Liu Z, Dillin A, Hunter T (2009) A conserved
ubiquitination pathway determines longevity in response to diet
restriction. Nature 460:396–399
Classon M, Kennedy BK, Mulloy R, Harlow E (2000) Opposing roles
of pRB and p107 in adipocyte differentiation. PNAS
97:10826–10831
CohenP,FriedmanJM(2004)Leptinandthecontrolofmetabolism:role
for stearoyl-CoA desaturase-1 (SCD-1). J Nutr 134:2455S–2463S
Cohen P, Ntambi JM, Friedman JM (2003) Stearoyl-CoA desaturase-1
and the metabolic syndrome. Endocr Metabol Disord 3:271–280
Davis RA (1999) Cell and molecular biology of the assembly and
secretion of apolipoprotein B-containing lipoproteins by the
liver. Biochim Biophys Acta 1440:1–31
3 Biotech (2011) 1:59–72 69
123Dobrzyn A, Ntambi JM (2005) Stearoyl-CoA desaturase as a new
drug target for obesity treatment. Obes Rev 6:169–174
Eaton S, Bartlett K, Pourfarzam M (1996) Mammalian mitochondrial
beta-oxidation. Biochem J 320:345–357
Ewbank JJ, Barnes TM, Lakowski B, Lussier M, Bussey H, Hekimi S
(1997) Structural and functional conservation of the Caenorhab-
ditis elegans timing gene clk-1. Science 275:980–983
Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril MB,
Miard S, Auwerx J (2002) The retinoblastoma-histone deacetyl-
ase 3 complex inhibits PPARgamma and adipocyte differenti-
ation. Dev Cell 3:903–910
Farmer SR (2006) Transcriptional control of adipocyte formation.
Cell Metab 4:263–273
Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel-Bellan A
(2001) The Rb/chromatin connection and epigenetic control:
opinion. Oncogene 20:3128–3133
Giannakou ME, Goss M, Ju ¨nger MA, Hafen E, Leevers SJ, Partridge
L (2004) Long-lived Drosophila with over-expressed dFOXO in
adult fat body. Science 305:361
Gordon DA, Jamil H (2000) Progress towards understanding the role
of microsomal triglyceride transfer protein in apolipoprotein-B
lipoprotein assembly. Biochim Biophys Acta 1486:72–83
Gordon DA, Jamil H, Sharp D, Mullaney D, Yao Z, Gregg RE,
Wetterau J (1994) Secretion of apolipoprotein B-containing
lipoproteins from HeLa cells is dependent on expression of the
microsomal triglyceride transfer protein and is regulated by lipid
availability. Proc Natl Acad Sci USA 91:7628–7632
Grant B, Hirsh D (1999) Receptor-mediated endocytosis in the
Caenorhabditis elegans oocyte. Mol Biol Cell 10:4311–4326
Gray S, Feinber MW, Hull S, Kuo CT, Watanabe M, Banerjee SS,
DePina A, Haspel R, Jain MK (2002) The Kru ¨ppel-like factor
KLF15 regulates the insulin-sensitive glucose transporter
GLUT4. J Biol Chem 277:34322–34328
Gray S, Wang B, Orihuela Y, Hong EG, Fisch S, Haldar S, Cline GW,
Kim JK, Peroni OD, Kahn BB, Jain MK (2007) Regulation of
gluconeogenesis by Kruppel-like factor 15. Cell Metab
5:305–312
Greer ER, Perez CL, Van Gilst MR, Lee BH, Ashraﬁ K (2008) Neural
and molecular dissection of a C. elegans sensory circuit that
regulates fat and feeding. Cell Metab 8:118–131
Haldar SM, Ibrahim OA, Jain MK (2007) Kruppel-like Factors
(KLFs) in muscle biology. J Mol Cell Cardiol 43:1–10
Hashmi S, Ji Q, Zhang J, Parhar R, Huang C-H, Brey C, Gaugler R
(2008) A Kru ¨ppel-like factor in Caenorhabditis elegans with
essential roles in fat regulation, cell death and phagocytosis.
DNA Cell Biol 27:545–551
Higgins JA, Hutson JL (1984) The roles of Golgi and endoplasmic
reticulum in the synthesis and assembly of lipoprotein lipids in
rat hepatocytes. J Lipid Res 25:1295–1305
Hodgkin J, Horvitz H, Jasny B, Kimble J (1998) C. elegans: sequence
to biology. Science 282:119–121
Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM,
Hoffman EP, Thyfault JP, Stevens R, Dohm GL, Houmard JA,
Muoio DM (2005) Elevated stearoyl-CoA desaturase-1 expres-
sion in skeletal muscle contributes to abnormal fatty acid
partitioning in obese humans. Cell Metab 2:251–261
Hussain MM, Iqbal J, Anwar K, Rava P, Dai K (2003) Microsomal
triglyceride transfer protein: a multifunctional protein. Front
Biosci 8:s500–s506
Hussain MM, Rava P, Pan X, Dai K, Dougan SK, Iqbal J, Lazare F,
Khatun I (2008) Microsomal triglyceride transfer protein in
plasma and cellular lipid metabolism. Curr Opin Lipidol
19:277–284
Hwangbo DS, Gershman B, Tu MP, Palmer M, Tatar M (2004)
Drosophila dFOXO controls lifespan and regulates insulin
signalling in brain and fat body. Nature 429:562–566
Jamil H, Dickson JK Jr, Chu CH, Lago MW, Rinehart JK, Biller SA,
Gregg RE, Wetterau JR (1995) Microsomal triglyceride transfer
protein, speciﬁcity of lipid biding and transport. J Biol Chem
270:6549–6554
Jeong PY, Jung M, Yim YH, Kim H, Park M, Hong E, Lee W, Kim
YH, Kim K, Paik YK (2005) Chemical structure and biological
activity of the Caenorhabditis elegans dauer-inducing phero-
mone. Nature 433:541–545
Jonassen T, Larsen PL, Clarke CF (2001) A dietary source of
coenzyme Q is essential for growth of long-lived Caenorhabditis
elegans clk-1 mutants. Proc Natl Acad Sci USA 98:421–426
Jones KT, Ashraﬁ K (2009) Caenorhabditis elegans as an emerging
model for studying the basic biology of obesity. Dis Model Mech
2:224–229
Kaczynski J, Cook T, Urrutia R (2003) Sp1- and Kru ¨ppel-like
transcription factors. Genome Biol 4:206–214
Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest
106:473–481
Kane JP, Hardman DA, Paulus HE (1980) Heterogeneity of apoli-
poprotein B: isolation of a new species from human chylomi-
crons. Proc Natl Acad Sci USA 77:2465–2469
Kang S, Davis RA (2000) Cholesterol and hepatic lipoprotein
assembly and secretion. Biochim Biophys Acta 1529:223–230
Kawamura Y, Tanaka Y, Kawamori R, Maeda S (2005) Over-
expression of Kru ¨ppel-like factor 7 (KLF7) regulates adipocy-
tokine gene expressions in human adipocytes, and inhibits
glucose-induced insulin secretion in pancreatic beta cell line.
Mol Endocrinol 20:844–856
Kimble J, Sharrock WJ (1983) Tissue-speciﬁc synthesis of yolk
proteins in Caenorhabditis elegans. Dev Biol 96:189–196
Kimura KD, Tissenbaum HA, Yanxia L, Ruvkun G (1997) Daf-2, an
insulin receptor-like gene that regulates longevity and diapause
in Caenorhabditis elegans. Science 277:942–946
Krishnaiah KL, Walker LR, Borensztain J, Schonfeld G, Getz GS
(1980) Apolipoprotein B variant derived from rat intestine. Proc
Natl Acad Sci USA 77:3806–3810
Leiper JM, Bayliss JD, Pease RJ, Brett DJ, Scott J, Shoulders CC
(1994) Microsomal triglyceride transfer protein, the abetalipo-
proteinemia gene product, mediates the secretion of apolipopro-
tein B-containing lipoproteins from heterologous cells. J Biol
Chem 269:21951–21954
Li D, Yea S, Li S, Chen Z, Narla G, Banck M, Laborda J, Tan S,
Friedman JM, Friedman SL, Walsh MJ (2005) Kru ¨ppel-like
factor-6 promotes preadipocyte differentiation through histone
deacetylase 3-dependent repression of DLK1. J Biol Chem
280:26941–26952
Lindsley JE, Rutter J (2004) Nutrient sensing and metabolic
decisions. Comp Biochem Physiol 139:543–559
Mair W, Dillin A (2008) Aging and survival: the genetics of life span
extension by dietary restriction. Annu Rev Biochem 77:727–754
Mann CJ, Anderson TA, Read J, Chester SA, Harrison GB, Kochl S,
Ritchie PJ, Bradbury P, Hussain FS, Amey J, Vanloo B,
Rosseneu M, Infante R, Hancock JM, Levitt DG, Banaszak LJ,
Scott J, Shoulders CC (1999) The structure of vitellogenin
provides a molecular model for the assembly and secretion of
atherogenic lipoproteins. J Mol Biol 285:391–408
Martin S, Parton RG (2006) Lipid droplets: a uniﬁed view of a
dynamic organelle. Nat Rev Mol Cell Biol 7:373–378
McKay RM, McKay JP, Avery L, Graff JM (2003) C. elegans:a
model for exploring the genetics of fat storage. Dev Cell
4:131–142
Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y,
Nakamura K, Nakamura T, Yamauchi T, Kubota N, Kadowaki
T, Matsuki Y, Ogawa W, Hiramatsu R, Kasuga M (2005) Role of
Kru ¨ppel-like transcription factor 15 (KLF15) in transcriptional
regulation of adipogenesis. J Biol Chem 280:12867–12875
70 3 Biotech (2011) 1:59–72
123Mullaney BC, Ashraﬁ K (2009) C. elegans fat storage and metabolic
regulation. Biochim Biophys Acta 1791:474–478
Muoio DM, Newgard CB (2008) Fatty acid oxidation and insulin
action: when less is more. Diabetes 57:1455–1456
Ntambi JM (1995) The regulation of stearoyl-CoA desaturase (SCD).
Prog Lipid Res 34:139–150
Ntambi JM, Miyazaki M, Dobryzn A (2004) Regulation of stearoyl-
CoA desaturase expression. Lipids 39:1061–1065
Oishi Y, Manabe I, Tobe K, Tsushima K,Shindo T, FujiuK, Nishimura
G, Maemura K, Yamauchi T, Kubota N, Suzuki R, Kitamura T,
Akira S, Kadowaki T, Nagai R (2005) Kru ¨ppel-like transcription
factor KLF5 is a key regulator of adipocyte differentiation. Cell
Metab 1:27–39
Oishi Y, Manabe I, Tobe K, Ohsugi M, Kubota T, Fujiu K, Maemura
K, Kubota N, Kadowaki T, Nagai R (2008) SUMOylation of
Kru ¨ppel-like transcription factors acting as a molecular switch in
transcription program of lipid metabolism involving PPAR-
delta. Nature Med 14:656–666
Osumi T, Hashimoto T, Ui N (1980) Puriﬁcation and properties of
acyl-CoA oxidase from rat liver. J Biochem 87:1735–1746
Patel SB, Grundy SM (1996) Interaction between microsomal
triglyceride transfer protein and apolipoprotein B within the
endoplasmic reticulum in a heterologous expression system.
J Biol Chem 271:18686–18694
Rava P, Hussain MM (2007) Acquisition of triacylglycerol transfer
activity by microsomal triglyceride transfer protein during
evolution. Biochemistry 46:12263–12274
Rava P, Ojakian GK, Shelness GS, Hussain MM (2006) Phospholipid
transfer activity of microsomal triacylglycerol transfer protein is
sufﬁcient for the assembly and secretion of apolipoprotein B
lipoproteins. J Biol Chem 281:11019–11027
Reaven GM (2005) Why syndrome X? From Harold Himsworth to
the insulin resistance syndrome. Cell Metab 1:9–14
Reddy JK, Hashimoto T (2001) Peroxisomal beta-oxidation and
peroxisome proliferator-activated receptor alpha: An adaptive
metabolic system. Annu Rev Nutr 21:193–230
Reddy K, Mannaerts GP (1994) Peroximal lipid metabolism. Annu
Rev Nutr 14:343–370
Ren P, Lim CS, Johnsen R, Albert PS, Pilgrim D, Riddle DL (1996)
Control of C. elegans larval development by neuronal expression
of a TGF-beta homolog. Science 274:1389–1391
Rosen ED, Spiegelman BM (2000a) Molecular regulation of adipo-
genesis. Annu Rev Cell Dev Biol 16:145–171
Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000b) Tran-
scriptional regulation of adipogenesis. Genes Dev 14:1293–1307
Rothstein M (1970) Nematode biochemistry. XI. Biosynthesis of fatty
acids by Caenorhabditis briggsae and Panagrellus redivivus. Int
J Biochem 1:422–428
Schedl T (1997) Developmental genetics of the germ line. In: Riddle
DL, Blumenthal T, Meyer BJ, Priess JR (eds) C. elegans II. Cold
Spring Harbor Laboratory Press, Plainview, pp. 241–269
Schwartz W, Woods C, Porte D Jr, Seeley J, Baskin DG (2000) Central
nervous system control of food intake. Nature 404:661–671
Sharrock WJ, Sutherlin ME, Leske K, Cheng TK, Kim TY (1990)
Two distinct yolk lipoprotein complexes from Caenorhabditis
elegans. J Biol Chem 265:14422–14431
Shibata Y, Branicky R, Landaverde IO, Hekimi S (2003) Redox
regulation of germline and vulval development in Caenorhab-
ditis elegans. Science 32:1779–1782
Simopoulos AP (1999) Essential fatty acids in health and chronic
disease. Am J Clin Nutr 70:560S–569S
Sparks CE, Marsh JB (1981) Metabolic heterogeneity of apolipopro-
tein B in the rat. J Lipid Res 22:519–527
Spieth J, Nettleton M, Zucker-Aprison E, Lea K, Blumenthal T
(1991) Vitellogenin motifs conserved in nematodes and verte-
brates. J Mol Evol 32:429–438
Sto ¨ger R (2008) The thrifty epigenotype: an acquired and heritable
predisposition for obesity and diabetes? BioEssays. 30:156–166
Sue N, Jack BHA, Eaton SS, Pearson RCM, Funnell APW, Turner J,
Czolij R, Denyer G, Bao S, Molero-Navajas JC, Perkin A,
Fujiwara Y, Orkin SH (2008) Targeted disruption of the basic
Kru ¨ppel-like factor gene (Klf3) reveals a role in adipogenesis.
Mol Cell Bio 28:3967–3978
Sundaram M, Zhong S, Bou Khalil M, Zhou H, Jiang ZG, Zhao Y,
Iqbal J, Hussain MM, Figeys D, Wang Y, Yao Z (2010)
Functional analysis of the missense APOC3 mutation Ala23Thr
associated with human hypotriglyceridemia. J Lipid Res
51:1524–1534
Sze JY, Victor M, Loer C, Shi Y, Ruvkun G (2000) Food and
metabolic signaling defects in a Caenorhabditis elegans seroto-
nin-synthesis mutant. Nature 403:560–564
The MuTHER Consortium, Small KS, Hedman AK, Grundberg E,
Nica AC, Thorleifsson G, Kong A, Thorsteindottir U, Shin SY,
Richards HB; the GIANT Consortium; the MAGIC Investiga-
tors; the DIAGRAM Consortium, Soranzo N, Ahmadi KR,
Lindgren CM, Stefansson K, Dermitzakis ET, Deloukas P,
Spector TD, McCarthy MI (2011). Identiﬁcation of an imprinted
master trans regulator at the KLF14 locus related to multiple
metabolic phenotypes. Nat Genet 43:561–564
TurnerJ,CrossleyM (1998)Cloning and characterization ofmCtBP2,a
co-repressorthatassociateswithbasicKru ¨ppel-likefactorandother
mammalian transcriptional regulators. EMBO J 17:5129–5140
Turner J, Crossley M (1999) Basic Kru ¨ppel-like factor functions
within a network of interacting haematopoietic transcription
factors. Int J Biochem Cell Biol 31:1169–1174
Van Gilst MR, Hadjivassiliou H, Jolly A, Yamamoto KR (2005)
Nuclear hormone receptor NHR-49 controls fat consumption and
fatty acid composition in C. elegans. PLoS Biol 3:301–312
van Vliet J, Crofts A, Quinlan G, Czolij R, Perkins C, Crossley M
(2006) Human KLF17 is a new member of the Sp/KLF family of
transcription factors. Genomics 87:474–482
Wade PA (2001) Transcriptional control at regulatory checkpoints by
histone deacetylases: molecular connections between cancer and
chromatin. Hum Mol Genet 10:693–698
Watts JL (2009) Fat synthesis and adiposity regulation in Caeno-
rhabditis elegans. Trends Endocrinol Metab 20:58–65
Watts JL, Browse J (2000) A palmitoyl-CoA-speciﬁc D9 fatty acid
desaturase from Caenorhabditis elegans. Biochem Biophys Res
Commun 272:263–269
Watts JL, Browse JA (2002) Genetic dissection of polyunsaturated
fatty acid synthesis in Caenorhabditis elegans. Proc Natl Acad
Sci USA 99:5854–5859
White J (1988) The anatomy. In: Wood WB (ed) The nematode
Ceanorhabditis elegans. Cold Spring Harbor Laboratory, New
York, pp 81–122
Wu X, Zhou M, Huang L-S, Wetterau J, Ginsberg HN (1996)
Demonstration of a physical interaction between microsomal
triglyceride transfer protein and Apolipoprotein B during the
assembly of ApoB-containing lipoproteins. J Biol Chem
271:10277–10281
Wu J, Srinivasan V, Neumann C, Lingrel JB (2005) The KLF2
transcription factor does not affect the formation of preadipo-
cytes but inhibits their differentiation into adipocytes. Biochem-
istry 44:11098–11105
Zhang P, Basu P, Redmond LC, Morris PE, Rupon JW, Ginder GD,
Lloyd JA (2005) A functional screen for Kru ¨ppel-like factors
that regulate the human gamma-globin gene through the CACCC
promoter element. Blood Cells Mol Dis 35:227–236
Zhang J, Yang C, Brey C, Rodriguez M, Oksov Y, Gaugler R, Hashmi
S (2009) Mutation in Caenorhabditis elegans Kru ¨ppel-like
factor, KLF-3 results in fat accumulation and alters fatty acid
composition. Exp Cell Res 315:2568–2580
3 Biotech (2011) 1:59–72 71
123Zhang SO, Box AC, Xu N, Le Men J, Yu J, Guo F, Trimble R, Mak
HO (2010) Genetic and dietary regulation of lipid droplet
expansion in Caenorhabditis elegans. Proc Nat Acad Sci USA
107:4640–4645
Zhang J, Bakheet R, Parhar RS, Huang C-H, Hussain MM, Pan X,
Siddiqui SS, Hashmi S (2011) Regulation of fat storage and
reproduction by Kru ¨ppel-like transcription factor KLF-3 and fat
associated genes in Caenorhabditis elegans. J. Mol. Biol. doi:
10.1016/j.jmb.2011.06.011
72 3 Biotech (2011) 1:59–72
123